GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cogstate Ltd (OTCPK:COGZF) » Definitions » 3-Year Book Growth Rate

Cogstate (Cogstate) 3-Year Book Growth Rate : 32.90% (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Cogstate 3-Year Book Growth Rate?

Cogstate's Book Value per Share for the quarter that ended in Dec. 2023 was $0.22.

During the past 12 months, Cogstate's average Book Value per Share Growth Rate was 14.50% per year. During the past 3 years, the average Book Value per Share Growth Rate was 32.90% per year. During the past 5 years, the average Book Value per Share Growth Rate was 22.10% per year. During the past 10 years, the average Book Value per Share Growth Rate was 9.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Cogstate was 43.80% per year. The lowest was -40.60% per year. And the median was 3.70% per year.

Competitive Comparison of Cogstate's 3-Year Book Growth Rate

For the Health Information Services subindustry, Cogstate's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cogstate's 3-Year Book Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cogstate's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Cogstate's 3-Year Book Growth Rate falls into.


Cogstate 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Cogstate  (OTCPK:COGZF) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Cogstate 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Cogstate's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Cogstate (Cogstate) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cogstate Ltd (OTCPK:COGZF) » Definitions » 3-Year Book Growth Rate
Comparable Companies
ASX:ONE ASX:VHT ASX:M7T ASX:MDR ASX:ALC ASX:BMT ASX:PCK ASX:RHT ASX:IME ASX:AYA GEHC VEEV SOLV TSE:2413 ASX:PME HQY RCM DOCS TXG EVH
Traded in Other Exchanges
CGS:Australia
Address
161 Collins Street, Level 2, Melbourne, VIC, AUS, 3000
Website
https://www.cogstate.com
Cogstate Ltd is a cognitive science company. The principal activity of the company is the sale of technology and services for the measurement of cognition, where services include scientific consultancy, project management, data management, statistical analysis, and reporting. Its operating segment includes Clinical Trials; Healthcare and Research. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services.